Embryo implantation in humans and rodents is a highly invasive yet tightly controlled process involving extracellular matrix (ECM) degradation. Matrix metalloproteinase 9 (MMP-9) has been implicated as the major facilitator of this ECM degradation. MMP-9 is expressed by the embryo's trophoblast cells, whereas tissue inhibitor of metalloproteinases 3 (TIMP-3) is expressed by the maternal uterine cells immediately adjacent to the trophoblast. We examined the functional roles of MMP-9 and TIMP-3 during in vitro ECM degradation by mouse embryos. Blastocysts were treated with either MMP-9 antisense or sense oligonucleotides and incubated on an ECM gel. The extent of ECM degradation exhibited by the blastocysts due to proteinase secretion was quantified. Embryos exposed to MMP-9 antisense oligonucleotides exhibited reduced ECM-degrading activity as compared with controls, and this reduced activity was correlated with the level of MMP-9 secreted by the embryos. The functional role of TIMP-3 was then examined by incubating blastocysts on an ECM gel that had been impregnated with various amounts of TIMP-3. In a dose-dependent manner, increases in TIMP-3 resulted in a reduction in ECM degradation and were correlated with diminished MMP-9 activity. These results provide important functional evidence that in vitro ECM degradation is regulated by embryo-derived MMP-9 and ECM-derived TIMP-3.
INTRODUCTION
Implantation in humans and rodents hinges on the ability of the embryo to degrade the basement membrane of the uterine epithelium and to invade the uterine stroma [1] . This process depends upon the trophoblast cells of the blastocyst stage embryo secreting proteinases capable of degrading the components of the basement membrane and underlying extracellular matrix (ECM) [2] . Recent studies have implicated the matrix metalloproteinases (MMPs), particularly MMP-9, as the major facilitator of ECM degradation during implantation [3] [4] [5] [6] . MMP-9 is the predominant MMP elaborated from implanting blastocysts, with expression beginning at around Day 6 when the blastocysts start to actively invade the maternal uterus [4, 5, 7] . Furthermore, MMP-9 is expressed in the peripheral network of trophoblast cells that are in close contact with the maternal deciduum [6] .
The activity of the MMPs is tightly controlled by the tissue inhibitor of metalloproteinases (TIMPs), which bind the catalytic domain of MMPs in a one-to-one stoichiometric interaction [8] . The active form of MMP-9 is inhibited by TIMP-1, TIMP-2 [9, 10] , and most effectively by TIMP-3 [11] . TIMP-1 and -2 are expressed at various stages of early development [4] [5] [6] 12] ; however, in situ hybridization studies have revealed that TIMP-3 is expressed by the maternal deciduum immediately apposed to the invading trophoblast cells at the time of implantation [6, 7, 13, 14] . TIMP-3 differs from the other TIMPs in that it is tightly bound to the ECM [15, 16] . This ECM association may be important in restricting invasive activity to the site of implantation.
The aim of this study was to determine the functional significance of MMP-9 and TIMP-3 expression during implantation. In particular, we investigated whether the ECMdegrading potential of the trophoblast, a vital component in the implantation process, hinges upon the levels of MMP-9 and TIMP-3 in the invading embryo and ECM, respectively.
MATERIALS AND METHODS

Antisense Oligonucleotides
An antisense oligonucleotide (5Ј-CTG CCA GGG ACT CAT GCG AAA GC) was designed against the initiation region of the published sequence for mouse MMP-9 [17] . A sense oligonucleotide (5Ј-ATG AGT CCC TGG CAG GCG AAA GC) was used to determine the nonspecific effects of oligonucleotides in the embryo culture system. An 8-base pair (bp) sequence (5Ј-GCG AAA GC-3Ј), which forms a stable hairpin structure resistant to 3Ј exonuclease activity [18, 19] , was included at the 3Ј end of each oligonucleotide. Oligonucleotides were synthesized by Bresatec Pty. Ltd. (Adelaide, Australia).
Embryo Culture
All procedures involving the use of animals were performed with approval from the Queensland University of Technology Animal Ethics Committee and in accordance with the National Health and Medical Research Council Code of Practice for Animal Research. Blastocysts were collected from Day 4 pregnant superovulated B6.CBA.F 1 mice. Mice were obtained from the Central Animal Breeding House, University of Queensland (Pinjarra Hills, Australia). To test the toxicity and efficiency of the oligonucleotides, groups of 10 blastocysts were cultured for 72 h in the presence of 30 M, 60 M, or 90 M sense or antisense oligonucleotides in 10-l droplets of Dulbecco modified medium (DMEM; Gibco BRL, Melbourne, Australia) supplemented with 5% fetal calf serum (FCS; Commonwealth Serum Laboratories, Mansfield, Aus- tralia). The oligonucleotides were nontoxic at concentrations up to and including 90 M. Toxicity was determined by monitoring the survival rates and morphological development of the blastocysts to Day 7 in culture. The effectiveness of the oligonucleotides was measured by gelatin zymography of the conditioned medium and analysis the inhibition of MMP-9 activity (data not shown). Day 4 blastocysts were then cultured in groups of 50 in 50-l droplets of DMEM with 5% FCS in the presence of 30 M, 60 M, or 90 M sense or antisense oligonucleotides. All cultures were performed at 37ЊC in a humidified atmosphere of 5% CO 2 in air. After 24 h, hatched blastocysts were transferred in groups of 10 to 24-well plates (Nunclon, Brisbane, Australia) coated with 120 l/ 1200 g of ECM gel (Sigma, St. Louis, MO), and culture was continued in DMEM (without FCS) with the same concentration of sense or antisense oligonucleotides as during the previous 24 h. A group of embryos cultured in the absence of oligonucleotides was included as a control. After 72 h, the conditioned medium was removed for assay by gelatin zymography, and the extent of embryo ECM degradation was visualized by staining the ECM gel cultures for 5 min in 0.5% Coomassie blue R250 (BioRad, Sydney, Australia) followed by destaining in H 2 O. The embryos/ECM gel cultures were then viewed with a Nikon TMS-F inverted microscope (Tokyo, Japan) and photographed with a Leica MPS30 microscope camera (Heerbrugg, Switzerland).
Supplementation of ECM Gel with ECM from BHK Cells and BHK Cells Transfected with Mouse TIMP-3
Baby hamster kidney (BHK) cells that had been transfected with a methotrexate-resistant expression cassette of the mouse TIMP-3 gene (designated BHK-MT3 cells) were used as the source of TIMP-3. In addition, BHK cells transfected with a methotrexate-resistant cassette but without the mouse TIMP-3 gene (designated BHK cells) were used as a control. All cells were maintained in DMEM/Ham F-12 (Gibco BRL) with 5% FCS and were treated with 0.1 mg/ ml methotrexate (Calbiochem, Alexandria, Australia) every five passages to ensure retention of the inserted expression cassette. All cells were grown to 70% confluency. The ECM was harvested, diluted 1:2 in DMEM, and reduced threefold with a Savant Speed Vac SC110. The total protein content was then evaluated using the Lowry protein assay [20] . Once the total amount of protein within the sample was determined, various amounts of the harvested ECM were incorporated into an ECM gel. Amounts of BHK-MT3 and BHK ECM incorporated into the ECM gel ranged from 6 g to 30 g total protein, corresponding to 0.05 g ECM/ l ECM gel to 0.25 g ECM/l ECM gel made up to a total volume of 120 l/1200 g with ECM gel. Reverse zymography was performed on these samples to visualize the level of TIMP activity in these ECM preparations. These gel mixtures were then used to coat the wells of 24-well plates. The plates were then incubated at 37ЊC for 30 min to solidify the gel. DMEM (120 l) was added to each well, and the plates were again incubated at 37ЊC for 1 h. Hatched Day 5 blastocysts that had been cultured for 24 h in 50-l droplets of DMEM containing 5% FCS were transferred in groups of eight to the ECM-coated wells. After 72 h of culture, the conditioned medium from each well was assayed by gelatin zymography, and the extent of ECM degradation was visualized by Coomassie blue staining.
Gelatin Zymography
For each ECM degradation experiment (performed at least five times), equivalent amounts of conditioned medi- um were assayed for MMP-9 activity by gelatin zymography [3, 6] twice. Up to 25 l of conditioned medium (normalized according to the number of embryos in each well) in an equal volume of 2ϫ Laemmli SDS gel loading buffer was electrophoresed on a 0.1% SDS/10% polyacrylamide gel copolymerized with 1 mg/ml gelatin (Sigma). The gels were then washed with 2.5% Triton-X-100 for 30 min and incubated in 50 mM Tris-HCl and 10 mM CaCl 2 (pH 7.8) at 37ЊC for 48 h. MMP activity was visualized as clear bands after staining with 0.5% Coomassie blue R250 for 2 h followed by destaining. All other materials are from Merck (Victoria, Australia).
Reverse Zymography
Reverse zymography [16] was used to assess the relative amounts of TIMP-3 in the ECM gel mixtures. This method detects inhibition of gelatinase activity in a 0.1% SDS/12% polyacrylamide gel copolymerized with 6% proteinase solution and 1 mg/ml gelatin. The proteinase solution was comprised of conditioned medium from BHK cells that had been transfected with the mouse MMP-9 gene. Six, 15, and 30 g of DMEM/ECM mixtures (representing the amounts added to each well) were loaded after being solubilized in an equal volume of 2ϫ Laemmli SDS gel loading buffer. Following electrophoresis, the gels were washed with 2.5% Triton-X-100 for 30 min. The gels were then incubated in 50 mM Tris-HCl and 10 mM CaCl 2 (pH 7.8) at 37ЊC for 48 h and stained with 0.5% Coomassie blue R250 for 4 h followed by destaining to reveal TIMP bands.
RESULTS
Antisense Oligonucleotide Inhibition of Embryo-Derived MMP-9 Activity
To determine the effect of inhibition of MMP-9 synthesis on the ECM-degrading ability of peri-implantation mouse embryos, blastocysts were cultured on an ECM gel in the presence of MMP-9 antisense oligonucleotides. Mouse blastocysts cultured on an ECM gel secrete proteinases that degrade ECM proteins in the local vicinity. Following culture, the addition of Coomassie blue stains the embryo blue/black and the ECM gel blue. The zones of clearing surrounding the embryo are a result of ECM degradation by proteinases secreted by the embryo. This experiment was repeated at least five times with a similar pattern of inhibition observed in each replicate. Figure 1 is representative of this pattern. The results show that embryos cultured for 72 h in either control medium (no oligonucleotides) or medium containing 90 M MMP-9 sense oligonucleotides exhibit a similar extent of ECM degradation (Fig. 1, A and B) . However, as the concentration of antisense oligonucleotides was increased, the amount of ECM degradation decreased (Fig. 1, C and D) , and in cultures containing 90 M MMP-9 antisense oligonucleotides, no degradation was observed (Fig. 1E) . The zones of clearing surrounding the embryos were quantified by ImageQuaNT (version 4.2, build 11; Molecular Dynamics, Sunnydale, CA), and these data were analyzed by a one-way analysis of variance (ANOVA) and the Tukey post hoc test (SPSS for Windows, Chicago, IL; Fig. 2 ). These differences were significant (P Ͻ 0.05).
The efficiency of the antisense oligonucleotides to inhibit MMP-9 synthesis in early embryos was ascertained by gelatin zymography of the conditioned medium from the ECM gel cultures. Results show the presence of several bands in each sample (Fig. 3A) . By virtue of their molecular sizes and inhibition by divalent 10 mM EDTA (data not shown), these two higher molecular weight bands were identified as MMP-9. The band at M r ϭ 105 ϫ 10 3 is consistent with the latent form of mouse MMP-9, whereas the band at M r ϭ 95 ϫ 10 3 corresponds to activated MMP-9. A lower molecular weight band was identified as MMP-3 based on its size (approximately M r ϭ 40 ϫ 10 3 ) and substrate specificity (it could also degrade casein). The secretion of MMP-3 by mouse blastocysts has been reported by others [3] . Comparison of the conditioned medium from control (no oligonucleotides), 90 M sense-treated, and 30 M antisense-treated blastocysts showed little differences in the levels of MMP activity (Fig. 3A, lanes 2-4) . However, a dose-dependent inhibition of MMP-9 activity was seen in the conditioned medium from embryos incubated with 60 and 90 M MMP-9 antisense oligonucleotides (Fig. 3A, lanes 5 and 6) . MMP-3 activity was comparable (Fig. 3A, lanes 2-6) . Densitometry was performed on the MMP bands in the gelatin zymograms (ImageQuaNT), and the quantitative data are shown as histograms (Fig. 3B) .
Effect of TIMP-3 on Embryo ECM Degradation
The total protein in the ECM collected from BHK cells and BHK-MT3 cells was quantified by the Lowry protein assay [20] to ensure that equivalent amounts of ECM protein were added to the ECM gel for each treatment. Reverse zymographic analyses of ECM derived from cultured BHK cells (at concentrations of 0.05 g/l, 0.125 g/l, and 0.25 g/l; Fig. 4 , lanes 1, 2, and 3, respectively) did not exhibit significant levels of MMP inhibitory activity. However, analysis of ECM derived from BHK-MT3 cells showed several major bands indicative of TIMP-3 activity (Fig. 4, lanes 4-6) . In particular, the band migrating at M r ϭ 27 ϫ 10 3 is consistent with glycosylated mouse TIMP-3 [16, 21] . The band at M r ϭ 24 ϫ 10 3 is likely to be the nonglycosylated form of mouse TIMP-3 [16, 21] . The other bands probably correspond to aggregates or cleaved fragments of TIMP-3 [16] . As expected, the amount of TIMP-3 activity in these samples was related in a dose-dependent manner to the amount of total ECM added (Fig. 4, lanes  4-6) .
Substantial differences in ECM degradation were observed when blastocysts were grown on an ECM gel supplemented with various amounts of BHK and BHK-MT3 ECM. Blastocysts grown on the ECM gel alone (Fig. 5A) or on an ECM gel supplemented with any concentration of BHK ECM (Fig. 5, B-D) showed similar ECM degradation. However, a notable decrease in the extent of ECM degradation was observed when blastocysts were cultured on 0.05 g/l BHK-MT3 ECM (Fig. 5E ) or 0.125 g/l BHK-MT3 ECM (Fig. 5F ). Blastocysts failed to attach to the ECM gel supplemented with 0.25 g/l BHK-MT3 ECM. These differences, quantified by densitometry, were analyzed by a one-way ANOVA and the Tukey post hoc test and were significant (P Ͻ 0.05) (Fig. 6) .
There also appeared to be a difference in the morphology of the blastocysts exposed to TIMP-3 compared with those exposed to MMP-9 antisense oligonucleotides (Fig. 5, E and F, compared with Fig. 1, D and E) . The extent of trophoblast outgrowth appeared to be greater in the TIMP-3-inhibited embryos than in the MMP-9 antisense-treated embryos. However, more definitive morphological assessment would be required to confirm these results. Both MMP-9 antisense-treated and TIMP-3-inhibited embryos also had smaller inner cell mass/egg cylinders than did controls.
Zymographic analyses of the conditioned medium taken from embryos grown on an ECM gel alone (Fig. 5A) or on an ECM gel supplemented with any concentration of BHK ECM (Fig. 5, B-D) showed bands of similar intensity consistent with latent and activated MMP-9 (Fig. 7A, lanes 2-5) . However, there was a slightly dose-dependent decrease in the amounts of both latent and, to a greater extent, activated MMP-9 in the medium taken from embryos that had been grown on an ECM gel supplemented with increasing levels of TIMP-3 (Fig. 7A, lanes 6 and 7) . Moreover, no MMP-9 activity was detected in the medium from embryos cultured on the highest dose of TIMP-3 (Fig. 7A, lane 8) . Again, densitometry was performed on the MMP-9 and MMP-3 bands in the gelatin zymograms. The densitometry measurements of these bands are expressed as histograms (Fig. 7B) . These data suggest that the presence of TIMP-3 in the ECM has a role in the regulation of MMP-9 production by the embryos.
DISCUSSION
The ECM degradation that facilitates cell invasion by the trophoblast cells of the embryo is a fundamental aspect of implantation. The correct balance between the activity of MMPs and their inhibition by TIMPs is crucial in the regulation of cell invasion in several cancer models [22, 23] . The expression of MMP-9 by the embryo and TIMP-3 by the adjacent maternal deciduum suggests the involvement of these two factors during implantation [6, 7, 13, 14] . To date, there have been limited functional studies to support this hypothesis. In the present study, we used a functional in vitro assay and two experimental approaches to examine the roles of embryo-derived MMP-9 and ECMderived TIMP-3 during ECM degradation by mouse embryos. Our objective was to mimic the close spatial relationship between the embryo and the maternal ECM. The first approach involved the use of antisense oligonucleotides to downregulate embryonic production of MMP-9, and the second approach involved incorporating ECMbound TIMP-3 into an artificial ECM gel on which the embryos were grown.
When antisense oligonucleotides directed against MMP-9
were added to the culture medium of blastocysts growing on ECM gel, the ECM degradation exhibited by these embryos was inhibited in a dose-dependent manner (Fig. 1 , C-E). This inhibition was correlated with a dose-dependent downregulation of MMP-9 activity by these embryos (Fig.  2) . These results indicate that MMP-9 is an important proteinase involved in ECM degradation and are consistent with an earlier report that neutralizing antibodies against MMP-9 block invasion and degradation of basement membranes by mouse blastocysts [5] . The targeted gene deletion of MMP-9 in mice does not show any phenotype or perturbations in implantation ability [24] . However, as indicated by many other knockout studies of genes from multigene families, phenotypes are often not observed and may be explained by genetic redundancy in these animals. It is also possible that other metalloproteinase genes may be upregulated to compensate for the absence of MMP-9 in these mutants. A candidate for an upregulated gene is ADAM-17, a member of the metalloproteinase superfamily that possess both a disintegrin and metalloproteinase domain. We have used reverse transcription polymerase chain reaction techniques to show that ADAM-17 is expressed in blastocysts [25] . Furthermore, the targeted gene deletion of ADAM-17 in mice results in placental defects in the fetuses [26] , and ADAM-17 is inhibited by TIMP-3 [27] . Several expression studies have implicated TIMP-3 as a regulator of blastocyst invasion during implantation [6, 13, 14] . In the present study, we investigated the functional significance of TIMP-3 at the embryo/ECM interface. In comparison with embryos cultured on ECM gels without TIMP-3, those embryos cultured on TIMP-3-impregnated ECM gels exhibited markedly reduced ECM degradation. This inhibition was correlated with a reduction in MMP-9 levels in the conditioned medium of TIMP-3-exposed embryos. The mechanism by which TIMP-3 accomplishes this downregulation of MMP-9 is not known. Because in most cases TIMPs bind active MMPs [28] , the observation that both active and, to a lesser extent, latent forms of MMP-9 were downregulated by TIMP-3 is interesting. It may be that TIMP-3 is involved in an intracellular signalling pathway that actually inhibits MMP-9 expression. In an earlier study, TIMP-1 stimulated the gene expression of type IV collagen and laminin [29] . It is also plausible that TIMP-3 is actually inhibiting the activation of latent MMP-9. Some TIMPs have been shown to bind to the latent forms of both MMP-2 and MMP-9 and therefore prevent subsequent activation [30] [31] [32] [33] .
There appears to be a difference in the morphology of the blastocyst outgrowths exposed to TIMP-3 compared with those exposed to MMP-9 antisense oligonucleotides. The TIMP-3-inhibited embryos appeared to have substantially greater trophoblast outgrowths than did the MMP-9 antisense-inhibited embryos. This finding supports a secondary role for TIMP-3 in other developmental processes. Supplementation of the culture medium of early cow embryos with TIMP-1 can enhance their in vitro development [34] . TIMP-1 and -2 also exhibit growth-promoting activities in human cells [35] [36] [37] . Furthermore, TIMP-3 may be involved in cell differentiation and protection against apoptosis in the deciduum at the time of implantation [7] . Another intriguing observation was that the inner cell masses/egg cylinders appear to be smaller in both the MMP-9 antisense-treated embryos and the TIMP-3-inhibited embryos, as compared with controls. The reason for this reduction in size is unclear. The MMP-9/TIMP-3 axis may also be critical for inner cell mass development at this stage. Further studies are aimed at investigating this finding.
These results provide some of the first functional evidence that TIMP-3 inhibits in vitro ECM degradation by peri-implantation mouse embryos by inhibiting embryo-derived MMP-9. This new functional evidence supports the hypothesis that ECM degradation, a vital component in the implantation process, is regulated by the levels of MMP-9 secreted from the invading embryo and TIMP-3 levels in the adjacent ECM.
